• Login
    View Item 
    •   Home
    • Theses and Dissertations
    • Theses and Dissertations
    • View Item
    •   Home
    • Theses and Dissertations
    • Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Scholarly CommonsCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    About

    AboutCreative CommonsAugusta University LibrariesUSG Copyright Policy

    Statistics

    Display statistics

    Insights into the Arginine Paradox and the Role of Arginase in Diabetic Retinopathy

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Elms, Shawn, 2012.pdf
    Size:
    13.56Mb
    Format:
    PDF
    Download
    Authors
    Elms, Shawn
    Issue Date
    2012-12
    URI

    http://hdl.handle.net/10675.2/624186
    
    Metadata
    Show full item record
    Abstract
    Reduced production of nitric oxide (NO) is one of the first indications of endothelial dysfunction and precedes the development of many cardiovascular diseases. Arginase has been shown to be upregulated in cardiovascular disease and has been proposed as a mechanism to account for diminished NO production. Arginases consume L-arginine, the substrate for nitric oxide synthase (NOS), and L-arginine depletion is thought to reduce NOS-derived NO. However, this simple relationship is complicated by the L-arginine paradox. The paradox addresses the phenomenon that L-arginine concentrations in endothelial cells remain sufficiently high to support NO synthesis yet increasing Larginine externally drives increased production of NO. One mechanism proposed to explain this is compartmentalization of intracellular L-arginine into distinct pools. In the current study we investigated this concept by targeting eNOS and arginase to different locations within the cell. We first showed that supplemental L-arginine and L-citrulline dose-dependently increased NO production in a manner independent of the location of eNOS within the cell. Cytosolic arginase- I (Argl) and mitochondrial arginase-2 (Argll) inhibited eNOS activity equally regardless of where in the cell eNOS was expressed. Similarly, targeting Argl to different regions of the cell did not modify its ability to inhibit NO formation. These results argue against compartmentalization as the mechanism by which arginase inhibit eNOS. Further studies showed that arginasedependent inhibition of NO formation was prevented pharmacologically with arginase inhibitors. Also, arginase inhibition of NO production was absent in a catalytically inactive arginase mutant. Arginase did not co-immunoprccipitate with eNOS and the metabolic products of arginase or downstream enzymes did not contribute to reduced NO formation. Because of previous studies in animals and cell culture supporting the role of Argl specifically in vascular dysfunction, we aimed to investigate the role of Argl in the retinal vascular dysfunction of diabetic retinopathy (DR). Our hypothesis was that Argl could be a mediator in the vascular dysfunction associated with DR. While using a mouse funduscope to image the retinal vasculature, we infused acetylcholine or sodium nitroprusside intravenously into diabetic or normoglycemic control mice and measured vessel relaxation. Endothelium-dependent retinal vasorelaxation was impaired in diabetic mice ( 40°/o of control). Diabetic mice hemizygous for arginase- I (Argl -) had improved function of the retinal vessels (71% of control). Endothelium-independent vasorelaxation was similar in diabetic and control, Argl - and wild type mice, indicating that the diabetes effect was specifically an endothelial issue and not one of smooth muscle dysfunction. Arginase inhibitors were shown to be effective in improving vascular function and reducing arginase activity. Further experiments were conducted in isolated central retinal arteries of diabetic and control rats, which recapitulated the results found in the mouse. We found that pharmacologic inhibition in both mice and rats or partial knock out of Argl in mice resulted in improvement in the retinal vascular dysfunction associated with DR. We conclude that Argl is a potential player in the retinal vascular dysfunction of DR.
    Affiliation
    Medical College of Georgia
    Collections
    Theses and Dissertations

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.